AccessPak for HIV PEP Expanded with Kaletra and Certolizumab Subcutaneous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Certolizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: certolizumab
Brand name: Cimzia, Cimzia Starter
Synonyms: Certolizumab, Certolizumab Pegol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Certolizumab Vials
- AccessPak for HIV PEP Expanded with Kaletra-Cerubidine
- AccessPak for HIV PEP Expanded with Kaletra-Cervarix
- AccessPak for HIV PEP Expanded with Kaletra-Cervarix Intramuscular
- AccessPak for HIV PEP Expanded with Kaletra-Cervidil
- AccessPak for HIV PEP Expanded with Kaletra-Cesamet
- Certolizumab Subcutaneous-AccessPak for HIV PEP Expanded with Viracept
- Certolizumab Subcutaneous-Accolate
- Certolizumab Subcutaneous-Accretropin
- Certolizumab Subcutaneous-Accucaine
- Certolizumab Subcutaneous-AccuHist Drops
- Certolizumab Subcutaneous-AccuHist PDX Drops